SST Gene Hypermethylation Acts as a Pan-Cancer Marker for Pancreatic Ductal Adenocarcinoma and Multiple Other Tumors; Toward Its Use for Blood-Based Diagnosis

Molecular Oncology - Netherlands
doi 10.1002/1878-0261.12684
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Promoter Hypermethylation in Plasma-Derived Cell-Free DNA as a Prognostic Marker for Pancreatic Adenocarcinoma Staging

International Journal of Cancer
Cancer ResearchOncology
2017English

TM4SF1 as a Prognostic Marker of Pancreatic Ductal Adenocarcinoma Is Involved in Migration and Invasion of Cancer Cells

International Journal of Oncology
Cancer ResearchOncology
2015English

Predictors for Survival in Patients Undergoing Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma (DIPLOMA): A Pan-European Cohort

HPB
HepatologyGastroenterology
2018English

Fibrosis-Related miRNAs as Serum Biomarkers for Pancreatic Ductal Adenocarcinoma

Oncotarget
Oncology
2017English

A PD-L2-based Immune Marker Signature Helps to Predict Survival in Resected Pancreatic Ductal Adenocarcinoma

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2019English

Infiltrating Immune Cells and Gene Mutations in Pancreatic Ductal Adenocarcinoma

British Journal of Surgery
Surgery
2016English

Ascites-Derived Pancreatic Ductal Adenocarcinoma Primary Cell Cultures as a Platform for Personalised Medicine

British Journal of Cancer
Cancer ResearchOncology
2014English

Five Key lncRNAs Considered as Prognostic Targets for Predicting Pancreatic Ductal Adenocarcinoma

Journal of Cellular Biochemistry
BiochemistryCell BiologyMolecular Biology
2018English

Image-Based Molecular Phenotyping of Pancreatic Ductal Adenocarcinoma

Journal of Clinical Medicine
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy